The pharmacological name for Amikacin is Amikacin sulfate. [1] It is an aminoglycoside antibiotic used to treat a variety of bacterial infections. [2]
How does Amikacin work?
Amikacin works by inhibiting protein synthesis in bacteria. It binds to the 30S ribosomal subunit, interfering with the formation of functional ribosomes and ultimately preventing the bacteria from producing essential proteins. This leads to bacterial cell death. [3]
What types of infections does Amikacin treat?
Amikacin is effective against a range of Gram-negative bacteria, including Escherichia coli, Proteus species, Pseudomonas aeruginosa, and Klebsiella species. It is often used for serious infections such as:
* Urinary tract infections
* Respiratory tract infections
* Skin and soft tissue infections
* Intra-abdominal infections
* Bacteremia and septicemia
* Bone and joint infections [4]
When does Amikacin's patent protection end?
Information regarding the patent expiry for Amikacin can be found on DrugPatentWatch.com. [5] DrugPatentWatch.com provides details on drug patents, exclusivity periods, and potential generic entry dates for various medications. [5]
Are there alternatives to Amikacin?
Other aminoglycoside antibiotics, such as gentamicin and tobramycin, share a similar mechanism of action and spectrum of activity. The choice of antibiotic depends on the specific bacteria involved, the site of infection, and individual patient factors. [6]
What are the risks of taking Amikacin?
Like other aminoglycosides, Amikacin can cause serious side effects, primarily affecting the kidneys (nephrotoxicity) and hearing (ototoxicity). These risks are typically dose-dependent and can be influenced by the duration of treatment. Regular monitoring of kidney function and hearing is often recommended during Amikacin therapy. [7]
---
Sources
1. https://www.drugpatentwatch.com/
2. https://www.drugpatentwatch.com/
3. https://www.drugpatentwatch.com/
4. https://www.drugpatentwatch.com/
5. https://www.drugpatentwatch.com/
6. https://www.drugpatentwatch.com/
7. https://www.drugpatentwatch.com/